Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABM, Akeso, Alvotech, Ardelyx, Biogen, Daewoong Pharmaceuticals, Everest Medicines, Hutchmed, Remegen, Shionogi, Takeda Pharmaceutical.